Investment
Features
FeesSafety
Academy
More
Pluang+

Compare McKesson Corporation (MCK) vs Sprott Uranium Miners ETF (URNM) Price & Performance

McKesson CorporationTrade
Sprott Uranium Miners ETFTrade

Price performance (Past 24H)

Key statistics

McKesson Corporation vs Sprott Uranium Miners ETF — how do they compare? McKesson Corporation trades at $936.87 (market cap $108.46B), while Sprott Uranium Miners ETF trades at $46.24 (market cap $1.87B). The key difference: McKesson Corporation is far larger — about 58× Sprott Uranium Miners ETF's market cap, and McKesson Corporation pays a 0.4% dividend while Sprott Uranium Miners ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Sprott Uranium Miners ETF for 60 Days on average.

MCKURNM
Market Cap
$108.46B$1.87B
Volume
712,6071,586,926
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$995.69$83.99
52-Week Low
$725.17$46.09
Typical Hold Time
74 Days60 Days
Enterprise Value
$115.00B—
Dividend Yield
0.4%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

McKesson Corporation

McKesson Corporation (MCK) trades at $937.98, up 3.04% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent positive developments include the CVS Health partnership extension through 2032 and raised full-year guidance. Revenue growth remains robust at $359.05 billion for 2025, though net margins are thin at 1.12%.

The outlook remains positive with 81% analyst buy ratings and a $956.43 consensus target. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. Strong cash flow generation ($6.09B operating cash flow) supports the dividend and growth initiatives, while technical indicators show the stock testing resistance near $938.

Sprott Uranium Miners ETF

URNM (Sprott Uranium Miners ETF) trades at $47.87, down 4.83% today amid bearish technical signals. The ETF faces selling pressure with 13 bearish moving average indicators, though oscillators remain neutral. Recent news highlights uranium's long-term growth potential driven by AI energy demand and government nuclear investments, with spot uranium prices rising 21.25% over the past year according to Sprott Asset Management (September 2026).

The uranium sector shows strong fundamental tailwinds from nuclear energy expansion and AI power needs, but URNM's technical weakness suggests near-term volatility. Investment opportunity exists in uranium supply deficits and contracting growth, while risks include ETF concentration and commodity price sensitivity.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MCK
40% Buy60% Sell
Avg holding period · 74 Days
URNM
100% Buy0% Sell
Avg holding period · 60 Days

Top news

Latest headlines on both assets

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK →

About Sprott Uranium Miners ETF

URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.

Read more on URNM →